Health CatalystHCAT -1.71%49 Current Ratio is 1.69 as of Mar. 2026, which is 55% below its 10-year median of 3.75. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $5.07 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Health Catalyst ranks better than 57.98% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Health Catalyst's current ratio for the quarter that ended in Mar. 2026 was 1.69.
Health Catalyst has a current ratio of 1.69. It generally indicates good short-term financial strength.
The historical rank and industry rank for Health Catalyst's Current Ratio or its related term are showing as below:
HCAT'
s Current Ratio Range Over the Past 10 Years
Min: 1.18 Med: 3.75 Max: 7.91
Current: 1.69
During the past 9 years, Health Catalyst's highest Current Ratio was 7.91. The lowest was 1.18. And the median was 3.75.
HCAT's Current Ratio is ranked better than 57.98% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs HCAT: 1.69
Health Catalyst (NAS:HCAT) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Health Catalyst Current Ratio Related Terms
Health Catalyst Current Ratio Historical Data
* Premium members only.
The historical data trend for Health Catalyst's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Health Catalyst's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Current Ratio distribution charts can be found below:
* The bar in red indicates where Health Catalyst's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (HCAT) has a Current Ratio of 1.69 as of Mar. 2026. This is 55% below median its historical median of 3.75. Over the past decade, Health Catalyst's Current Ratio has ranged from 1.18 to 7.91. According to the industry distribution chart, Health Catalyst ranks #287 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 42%.
Is Health Catalyst's Current Ratio too high?
Health Catalyst's current Current Ratio of 1.69 is 55% below median its 10-year median of 3.75. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 7.91. The Healthcare Providers & Services industry median Current Ratio is 1.47. Health Catalyst's value of 1.69 is 15% above this industry median. Based on the distribution chart, Health Catalyst ranks #287 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Current Ratio compare to CCLD and DH?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #287 out of 683 companies for Current Ratio. This puts Health Catalyst in the upper half of its industry. The industry median Current Ratio is 1.47. Health Catalyst's value of 1.69 is 15% above this benchmark. Historically, Health Catalyst's own Current Ratio has ranged from 1.18 to 7.91 over the past decade. While the company's 10-year median is 3.75 vs. the industry median of 1.47, Health Catalyst has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current Current Ratio of 1.69 is 15% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current Current Ratio is 1.69, which is 55% below median its own 10-year median of 3.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.07, compared to a current price of $1.72 — trading 66.1% below its estimated fair value. The current Current Ratio is 1.69, which is 55% below median its 10-year median of 3.75 and 15% above the Healthcare Providers & Services industry median of 1.47. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Current Ratio is 1.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $1.72 is trading 66.1% below its estimated GF Value™ of $5.07.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
Current Ratio: 1.69 (55% below median its 10-year median of 3.75)
GF Value™: $5.07 vs. price of $1.72 (66.1% below fair value)
Industry Position: 15% above the Healthcare Providers & Services median (#287 of 683)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
